cancer and semaglutide Clinical Impact of Beyond Glycemic Control: A Critical Analysis of Oncogenic Potential Mitigation of Cardiotoxicity GLP-1 drugs and cancer: the

As expected, the reduction in visceral fat area was significantly and positively correlated with changes in waist circumference, body fat percentage and BMI (Fig

Larzelere MM, Wiseman P

This means it stimulates GLP-1 receptors to reduce appetite and enhance insulin secretion, while blocking GIP signaling, which may help prevent fat storage

While these variants do not predict exact medication response, they can inform a more targeted clinical conversation with your provider about whether GLP-1 therapy aligns with your metabolic physiology

It gets fibroblasts working again, speeds up how quickly skin repairs itself, and directly supports hair follicle health from the root